Rapid test (RT) is the principal screening method in the HIV control practice. However, this method may lead to inaccurate detection, primarily due to the more than 4 weeks of window phase. In the present study, we performed a HIV DNA screening method to show its application prospects in men who have sex with men (MSM). From July 2017 to April 2018, we recruited 1,301 MSM from Beijing who were not previously diagnosed as HIV positive. Both HIV DNA detection and RT were performed. In total, 141 and 135 HIV-positive results were detected by DNA detection and RT, respectively. By repetitive and confirmative tests (Western blot), we verified that DNA detection detected 10 more true positives than RT and 4 false positives were corrected from RT. This represents 14 inaccurate RT results that were corrected by DNA measurement. Therefore, DNA measurement should be fully considered as a screening method in the detection of HIV among MSM in the future.
Get full access to this article
View all access options for this article.
References
1.
UNAIDS: 90-90-90: An Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva, Switzerland, UNAIDS Joint United Nations Programme on HIV/AIDS, 2014.
2.
WuZY: The progress and challenges of promoting HIV/AIDS 90-90-90 strategies in China [in Chinese]. Chin J Dis Control Prev, 2016; 20:1187–1189.
3.
ZhangL, ChowEPF, JingJ, et al.: HIV prevalence in China: Integration of surveillance data and a systematic review. Lancet Infect Dis, 2013; 13:955–963.
4.
LuL, JiaM, MaY, et al.: The changing face of HIV in China. Nature, 2008; 455:609–611.
5.
HillA, PozniakA: HIV treatment cascades: How can all countries reach the UNAIDS 90-90-90 target?. AIDS, 2015; 29:2523–2525.
6.
China MOH, UNAIDS WHO: HIV/AIDS Epidemic Estimation in China, 2011 [in Chinese]. Chin J AIDS STD, 2012; 18:1–5.
7.
ShangH, ZhangL: MSM and HIV-1 infection in China. Natl Sci Rev, 2015; 2:388–391.
8.
LuoS, HanL, LuH, et al.: Evaluating the impact of test-and-treat on the HIV epidemic among MSM in China using a mathematical model. PLoS One, 2015; 10:e0126893.
9.
WangX, LanG, ShenZ, et al.: HIV and syphilis prevalence trends among men who have sex with men in Guangxi, China: Yearly cross-sectional surveys, 2008–2012. BMC Infect Dis, 2014; 14:367.
10.
DongZ, XuJ, ZhangH, et al.: HIV incidence and risk factors in Chinese young men who have sex with men—A prospective cohort study. PLoS One, 2014; 9:e97527.
11.
BalajiAB, BowlesKE, LeBC, PazbaileyG, OsterAM: High HIV incidence and prevalence and associated factors among young MSM, 2008. AIDS, 2013; 27:269–278.
12.
ChowEPF, WilsonDP, ZhangL: The rate of HIV testing is increasing among men who have sex with men in China. HIV Med, 2012; 13:255–263.
13.
RoutyJP, CaoW, MehrajV: Overcoming the challenge of diagnosis of early HIV infection: A stepping stone to optimal patient management. Expert Rev Anti Infect Ther, 2015; 13:1189–1193.
14.
GilbertM, CookD, KwagM, et al.: Targeting screening and social marketing to increase detection of acute HIV infection in MSM in Vancouver, British Columbia. AIDS, 2013; 27:2649–2654.
FoxJ: Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: A cohort of high-risk men who have sex with men. HIV Med, 2009; 10:432–438.
17.
WilsonDP, HoareA, ReganDG, LawMG: Importance of promoting HIV testing for preventing secondary transmissions: Modelling the Australian HIV epidemic among men who have sex with men. Sex Health, 2009; 6:19–33.
18.
DongJ, WuY, ZhuH, et al.: A pilot study on screening blood donors with individual-donation nucleic acid testing in China. Blood Transfus, 2014; 12:172–179.
19.
CaiLN, ChenBA: Progress of improving blood donor screening by nucleic acid technology-review [in Chinese]. J Exp Hematol, 2014; 22:1171–1177.
20.
National Center for AIDS/STD Control and prevention, China CDC: National Guideline for Detection of HIV/AIDS. China, National Center for AIDS/STD Control and prevention, China CDC, 2015.
21.
LeT, WrightEJ, SmithDM, et al.: Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med, 2013; 368:218–230.
22.
BuzonMJ, MartingayoE, PereyraF, et al.: Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J Virol, 2014; 88:10056–10065.
23.
AnanworanichJ, SchuetzA, VandergeetenC, et al.: Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One, 2012; 7:e33948.
24.
PatelP: Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006–2008. Arch Intern Med, 2010; 170:66–74.
25.
BoyleDS, LehmanDA, LillisL, et al.: Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplification. MBio, 2013; 4:49–52.
26.
JangamSR, YamadaDH, McfallSM, KelsoDM: Rapid, point-of-care extraction of human immunodeficiency virus type 1 proviral DNA from whole blood for detection by real-time PCR. J Clin Microbiol, 2009; 47:2363–2368.
27.
OndiekJ, NamukayaZ, MtapurizinyoweraS, et al.: Multi-country validation of SAMBA—A novel molecular point-of-care test for HIV-1 detection in resource-limited setting. J Acquir Immune Defic Syndr, 2017; 76:52–57.
